Tiverton Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tiverton Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-115	Closed	-$10K	–	731
2019 Q1	$10K	Buy	+115	New	+$9.78K	﹤0.01%	650

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Tiverton Asset Management's XBI Position: Q2 2019 in Review

Tiverton Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 115 shares — an estimated $10K sold.

Tiverton Asset Management first reported a position in XBI in Q1 2019 and held it in 1 quarter. The position peaked at $10K in Q1 2019. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

Tiverton Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
Tiverton Asset Management sold 115 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $10K.
Tiverton Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 1 quarter.
Tiverton Asset Management's State Street SPDR S&P Biotech ETF position peaked at $10K in Q1 2019.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Tiverton Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.